David Jin

Insider Reports History

Entity
Individual
Location
C/O Avenue Therapeutics, Inc., 1140 Avenue Of The Americas, Floor 9, New York, NY
Signature
/s/ David Jin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Jin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fortress Biotech, Inc. Chief Financial Officer Common Stock, par value $0.001 241K $296K $1.23 Oct 1, 2024 Direct
AVENUE THERAPEUTICS, INC. Interim PFO and COO COMMON STOCK, PAR VALUE $0.0001 65K $9.1K $0.14 Sep 23, 2024 Direct
Fortress Biotech, Inc. Chief Financial Officer SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK 500 $4.67K $9.34 Jul 10, 2024 Direct
MUSTANG BIO, INC. Director Common Stock 1.99K $698 $0.35 Oct 23, 2024 Direct

Insider Reports Filed by David Jin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MBIO MUSTANG BIO, INC. Oct 23, 2024 0 $0 3 Oct 29, 2024 Director
FBIO Fortress Biotech, Inc. Oct 1, 2024 1 $3.22K 4 Oct 1, 2024 Chief Financial Officer
ATXI AVENUE THERAPEUTICS, INC. Sep 23, 2024 1 $0 4 Sep 25, 2024 Interim PFO and COO
FBIO Fortress Biotech, Inc. Jul 10, 2024 1 $3.75K 4 Jul 12, 2024 Chief Financial Officer
FBIO Fortress Biotech, Inc. Apr 1, 2024 1 $4K 4 Apr 2, 2024 Chief Financial Officer
FBIO Fortress Biotech, Inc. Dec 20, 2023 1 $0 4 Dec 22, 2023 Chief Financial Officer
ATXI AVENUE THERAPEUTICS, INC. Jun 30, 2023 1 $0 4 Jul 5, 2023 Interim PFO and COO
FBIO Fortress Biotech, Inc. Feb 10, 2023 1 $30K 4 Feb 14, 2023 Chief Financial Officer
FBIO Fortress Biotech, Inc. Nov 30, 2022 1 $2.8K 4 Dec 2, 2022 Chief Financial Officer
FBIO Fortress Biotech, Inc. Oct 26, 2022 1 $0 4 Oct 28, 2022 Chief Financial Officer
FBIO Fortress Biotech, Inc. Aug 16, 2022 0 $0 3 Aug 25, 2022 Chief Financial Officer
ATXI AVENUE THERAPEUTICS, INC. May 11, 2022 0 $0 3 May 25, 2022 Int. PEO, Int. PFO, and COO